Clinical trial
A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus…
NCT00369941 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00369941 |
|---|---|
| Title | A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) |
| Official title | A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA™ |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | MK-0518, Comparator: efavirenz, Comparator: Truvada, Comparator: Placebo to MK-0518, Comparator: Placebo to efavirenz |
| Enrollment | 566 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Feb 1, 2012 |
| First posted | Aug 30, 2006 |
| Last update posted | Mar 21, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: